Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
80.79
-0.88 (-1.08%)
Jun 8, 2026, 11:24 AM EDT - Market open
Revenue
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 24, 2020 | Apr '19 Apr 26, 2019 | Apr '18 Apr 27, 2018 | Apr '17 Apr 28, 2017 | Apr '16 Apr 29, 2016 | Apr '15 Apr 24, 2015 | Apr '14 Apr 25, 2014 | Apr '13 Apr 26, 2013 |
Cardiac Rhythm & Heart Failure Revenue | 7.50B | 6.39B | ||||||||||||
Cardiac Rhythm & Heart Failure Revenue Growth | 17.40% | 6.62% | ||||||||||||
Structural Heart & Aortic Revenue | 3.82B | 3.55B | ||||||||||||
Structural Heart & Aortic Revenue Growth | 7.40% | 5.84% | ||||||||||||
Coronary & Peripheral Vascular Revenue | 2.66B | 2.54B | ||||||||||||
Coronary & Peripheral Vascular Revenue Growth | 4.77% | 2.30% | ||||||||||||
Cardiovascular Revenue | 13.98B | 12.48B | ||||||||||||
Cardiovascular Revenue Growth | 11.98% | 5.49% | ||||||||||||
Cranial & Spinal Technologies Revenue | 5.22B | 4.97B | ||||||||||||
Cranial & Spinal Technologies Revenue Growth | 5.01% | 4.56% | ||||||||||||
Specialty Therapies Revenue | 3.00B | 2.94B | ||||||||||||
Specialty Therapies Revenue Growth | 1.94% | 1.21% | ||||||||||||
Neuromodulation Revenue | 2.07B | 1.93B | ||||||||||||
Neuromodulation Revenue Growth | 7.04% | 10.65% | ||||||||||||
Neuroscience Revenue | 10.29B | 9.85B | ||||||||||||
Neuroscience Revenue Growth | 4.48% | 4.68% | ||||||||||||
Surgical & Endoscopy Revenue | 6.76B | 6.50B | ||||||||||||
Surgical & Endoscopy Revenue Growth | 4.09% | -0.15% | ||||||||||||
Acute Care & Monitoring Revenue | 2.05B | 1.91B | ||||||||||||
Acute Care & Monitoring Revenue Growth | 7.44% | 0.05% | ||||||||||||
Medical Surgical Revenue | 8.82B | 8.41B | ||||||||||||
Medical Surgical Revenue Growth | 4.85% | -0.12% | ||||||||||||
Diabetes Revenue | 3.11B | 2.76B | ||||||||||||
Diabetes Revenue Growth | 12.96% | 10.73% | ||||||||||||
Other Segment Revenue | 174.00M | 48.00M | ||||||||||||
Other Segment Revenue Growth | 262.50% | -78.28% | ||||||||||||
Revenue (Other) | - | - | ||||||||||||
Revenue (Total) | 36.36B | 33.54B | ||||||||||||
Revenue (Total) Growth | 8.43% | 3.62% |
Revenue by Geography
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 24, 2020 | Apr '19 Apr 26, 2019 | Apr '18 Apr 27, 2018 | Apr '17 Apr 28, 2017 | Apr '16 Apr 29, 2016 | Apr '15 Apr 24, 2015 | Apr '14 Apr 25, 2014 | Apr '13 Apr 26, 2013 |
U.S. Revenue | 18.10B | 17.17B | ||||||||||||
U.S. Revenue Growth | 5.43% | 3.68% | ||||||||||||
Non-U.S. Developed Markets Revenue | - | 10.20B | ||||||||||||
Non-U.S. Developed Markets Revenue Growth | - | 2.21% | ||||||||||||
Emerging Markets Revenue | - | 6.20B | ||||||||||||
Emerging Markets Revenue Growth | - | 6.47% | ||||||||||||
Total International Revenue | 18.26B | 16.37B | ||||||||||||
Total International Revenue Growth | 11.59% | 3.56% | ||||||||||||
Revenue (Other) | - | 1.00M | ||||||||||||
Revenue (Total) | 36.36B | 33.54B | ||||||||||||
Revenue (Total) Growth | 8.43% | 3.62% |
EBIT
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 24, 2020 | Apr '19 Apr 26, 2019 | Apr '18 Apr 27, 2018 | Apr '17 Apr 28, 2017 | Apr '16 Apr 29, 2016 | Apr '15 Apr 24, 2015 | Apr '14 Apr 25, 2014 | Apr '13 Apr 26, 2013 |
Cardiovascular Operating Profit | - | 4.80B | ||||||||||||
Cardiovascular Operating Profit Growth | - | 7.31% | ||||||||||||
Neuroscience Operating Profit | - | 4.18B | ||||||||||||
Neuroscience Operating Profit Growth | - | 6.17% | ||||||||||||
Medical Surgical Operating Profit | - | 3.04B | ||||||||||||
Medical Surgical Operating Profit Growth | - | -4.04% | ||||||||||||
Diabetes Operating Profit | - | 491.00M | ||||||||||||
Diabetes Operating Profit Growth | - | 24.62% | ||||||||||||
Other Segment Operating Profit | - | 49.00M | ||||||||||||
Other Segment Operating Profit Growth | - | 390.00% | ||||||||||||
Operating Income (Total) | 6.47B | 5.96B | ||||||||||||
Operating Income (Total) Growth | 8.60% | 15.77% |
Key Performance Indicators
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 24, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 | Apr '20 Apr 24, 2020 | Apr '19 Apr 26, 2019 | Apr '18 Apr 27, 2018 | Apr '17 Apr 28, 2017 | Apr '16 Apr 29, 2016 | Apr '15 Apr 24, 2015 | Apr '14 Apr 25, 2014 | Apr '13 Apr 26, 2013 |
Cardiovascular Organic Revenue Growth | 9.30% | 6.30% | ||||||||||||
Neuroscience Organic Revenue Growth | 3.10% | 5.20% | ||||||||||||
Medical Surgical Organic Revenue Growth | 2.90% | 0.80% | ||||||||||||
Diabetes Organic Revenue Growth | 7.90% | 11.50% | ||||||||||||
Total Organic Revenue Growth | 5.80% | 4.90% |
Updated Jun 3, 2026. Data Source: Fiscal.ai.